KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Charles River Laboratories International (CRL) Current Leases: 2009-2018

Charles River Laboratories International's Current Leases was N/A to $3.2 million in Q4 2018 from the same period last year, while for Dec 2018 it was $3.2 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2018, which is N/A change from last year.
As of Q4 2018, Charles River Laboratories International's Current Leases stood at $3.2 million, which was down 99.99% from $23.9 billion recorded in Q4 2009.
Over the past 5 years, Charles River Laboratories International's Current Leases peaked at $3.2 million during Q4 2018, and registered a low of $3.2 million during Q4 2018.
Its 1-year average for Current Leases is $3.2 million, with a median of $3.2 million in 2018.